Cargando…

Corrigendum to “High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI”

Detalles Bibliográficos
Autores principales:	Ahmed, Sheikh Sohail, Unland, Tamara, Slaven, James E., Nitu, Mara E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469171/ https://www.ncbi.nlm.nih.gov/pubmed/26136786 http://dx.doi.org/10.1155/2015/235783

Ejemplares similares

High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI
por: Ahmed, Sheikh Sohail, et al.
Publicado: (2015)

Can dexmedetomidine be used as sole maintenance anesthetic agent at standard sedative doses?
por: Bihani, Pooja, et al.
Publicado: (2017)

Cost-Minimization Analysis of Dexmedetomidine Compared to Other Sedatives for Short-Term Sedation During Mechanical Ventilation in the United States [Corrigendum]
Publicado: (2020)

Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
Publicado: (2022)

Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial [Corrigendum]
Publicado: (2022)

Corrigendum to “Bradycardia Leading to Asystole Following Dexmedetomidine Infusion during Cataract Surgery: Dexmedetomidine-Induced Asystole for Cataract Surgery”
por: Amaniti, Aikaterini, et al.
Publicado: (2019)

Corrigendum to “Sedative and Hypnotic Activities of the Methanolic and Aqueous Extracts of Lavandula officinalis from Morocco”
por: Alnamer, Rachad, et al.
Publicado: (2020)

Efficacy of Chloral Hydrate Oral Solution for Sedation in Pediatrics: a Systematic Review and Meta-Analysis [Corrigendum]
Publicado: (2022)

A pilot study of ADRA2A genotype association with doses of dexmedetomidine for sedation in pediatric patients
por: Gallaway, Katherine A., et al.
Publicado: (2022)

The effects of different loading doses of dexmedetomidine on sedation
por: Sim, Jae Hwan, et al.
Publicado: (2014)

Dexmedetomidine for Sedation of Neonates with HIE Undergoing Therapeutic Hypothermia: A Single-Center Experience
por: O'Mara, Keliana, et al.
Publicado: (2018)

Corrigendum to “Abnormal brain connectivity in first-episode psychosis: A diffusion MRI tractography study of the corpus callosum” [NeuroImage 35 (2007) 458–466]
por: Price, Gary, et al.
Publicado: (2007)

Intranasal dexmedetomidine is an effective sedative agent for electroencephalography in children
por: Chen, Hang, et al.
Publicado: (2020)

Corrigendum to “Oral Adverse Reactions Caused by Over-the-Counter Oral Agents”
por: Boras, Vanja Vucicevic, et al.
Publicado: (2019)

Recent Advances in the Treatment of C. difficile Using Biotherapeutic Agents [Corrigendum]
Publicado: (2021)

Corrigendum to “Repurposing Napabucasin as an Antimicrobial Agent against Oral Streptococcal Biofilms”
por: Kuang, Xinyi, et al.
Publicado: (2021)

Corrigendum to “Dexmedetomidine Postconditioning Alleviates Hypoxia/Reoxygenation Injury in Senescent Myocardial Cells by Regulating lncRNA H19 and m6A Modification”
por: Zhang, Xuan, et al.
Publicado: (2020)

Efficacy and Safety of a Subanesthetic Dose of Esketamine Combined with Propofol in Patients with Obesity Undergoing Painless Gastroscopy: A Prospective, Double-Blind, Randomized Controlled Trial [Corrigendum]
Publicado: (2023)

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy [Corrigendum]
Publicado: (2022)

Corrigendum to “Erbium-Based Perfusion Contrast Agent for Small-Animal Microvessel Imaging”
por: Tse, Justin J., et al.
Publicado: (2018)

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults [Corrigendum]
Publicado: (2019)

Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
Publicado: (2021)

Corrigendum
por: Lipsky, Peter E.
Publicado: (2021)

Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations [Corrigendum]
Publicado: (2019)

Corrigendum to “Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma”
por: Fatima, Naz, et al.
Publicado: (2017)

Optimal dose of dexmedetomidine for sedation during spinal anesthesia
por: Ok, Hwoe-Gyeong, et al.
Publicado: (2013)

Autobiographical memory and default mode network function in schizophrenia: an fMRI study—CORRIGENDUM
por: Martin-Subero, Marta, et al.
Publicado: (2021)

Ropivacaine with Dexmedetomidine or Dexamethasone in a Thoracic Paravertebral Nerve Block Combined with an Erector Spinae Plane Block for Thoracoscopic Lobectomy Analgesia: A Randomized Controlled Trial [Corrigendum]
Publicado: (2022)

Corrigendum to “Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents” [J Hosp Infect 104 (2020) 246–251]
por: Kampf, G., et al.
Publicado: (2020)

Obstructive sleep apnea affects the clinical outcomes of patients undergoing percutaneous coronary intervention [Corrigendum]
Publicado: (2016)

Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
por: Cherin, Patrick, et al.
Publicado: (2015)

Corrigendum to “Benefits of Low-Dose CT Scan of Head for Patients with Intracranial Hemorrhage”
Publicado: (2021)

Corrigendum to “Fear Processing in Dental Phobia during Crossmodal Symptom Provocation: An fMRI Study”
por: Hilbert, Kevin, et al.
Publicado: (2018)

Concomitant Takayasu arteritis and Cushing syndrome in a child undergoing open adrenalectomy: An anaesthetic challenge: Corrigendum
por: Hemlata,, et al.
Publicado: (2014)

Corrigendum to “Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats”
por: Yu, Wenli, et al.
Publicado: (2021)

Dexmedetomidine sedation in ICU
por: Yu, Soo-Bong
Publicado: (2012)

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]
Publicado: (2014)

Corrigendum to “Improvement of Memory by Means of Ultra-Low Doses of Antibodies to S-100B Antigen”
por: Evidence-Based Complementary and Alternative Medicine,
Publicado: (2020)

Corrigendum to “CLIPPERS: Multiparametric and quantitative MRI features” [Radiology Case Reports 18 (2023) 368–376]
por: Korostyshevskaya, Alexandra M., et al.
Publicado: (2022)

Corrigendum to “Herbal Mouthwash Containing Extracts of Baccharis dracunculifolia as Agent for the Control of Biofilm: Clinical Evaluation in Humans”
por: Pedrazzi, Vinícius, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vlavm0j5b8pu06mu390vjchtuf